NO151239C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner

Info

Publication number
NO151239C
NO151239C NO790523A NO790523A NO151239C NO 151239 C NO151239 C NO 151239C NO 790523 A NO790523 A NO 790523A NO 790523 A NO790523 A NO 790523A NO 151239 C NO151239 C NO 151239C
Authority
NO
Norway
Prior art keywords
phenyliminoimidazolidines
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO790523A
Other languages
English (en)
Norwegian (no)
Other versions
NO790523L (no
NO151239B (no
Inventor
Helmut Staehle
Herbert Koeppe
Werner Kummer
Wolfgang Hoefke
Wolfram Gaida
Ludwig Pichler
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO790523L publication Critical patent/NO790523L/no
Publication of NO151239B publication Critical patent/NO151239B/no
Publication of NO151239C publication Critical patent/NO151239C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO790523A 1978-02-17 1979-02-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner NO151239C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782806775 DE2806775A1 (de) 1978-02-17 1978-02-17 Neue substituierte 2-phenylimino- imidazolidine deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben

Publications (3)

Publication Number Publication Date
NO790523L NO790523L (no) 1979-08-20
NO151239B NO151239B (no) 1984-11-26
NO151239C true NO151239C (no) 1985-03-06

Family

ID=6032231

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790523A NO151239C (no) 1978-02-17 1979-02-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner

Country Status (32)

Country Link
US (2) US4250186A (fr)
JP (1) JPS54122273A (fr)
AT (1) AT370093B (fr)
AU (1) AU519356B2 (fr)
BE (1) BE874252A (fr)
CA (1) CA1115717A (fr)
CH (1) CH640230A5 (fr)
CS (2) CS207774B2 (fr)
DD (1) DD142048A5 (fr)
DE (1) DE2806775A1 (fr)
DK (1) DK69479A (fr)
ES (2) ES477784A1 (fr)
FI (1) FI69301C (fr)
FR (1) FR2417502A1 (fr)
GB (1) GB2014575B (fr)
GR (2) GR67626B (fr)
HU (1) HU180430B (fr)
IE (1) IE48073B1 (fr)
IL (1) IL56678A (fr)
IT (1) IT1113469B (fr)
LU (1) LU80924A1 (fr)
NL (1) NL7901241A (fr)
NO (1) NO151239C (fr)
NZ (1) NZ189684A (fr)
PH (1) PH16188A (fr)
PL (2) PL115759B1 (fr)
PT (1) PT69239A (fr)
RO (2) RO81504B (fr)
SE (1) SE7901405L (fr)
SU (2) SU812175A3 (fr)
YU (1) YU36779A (fr)
ZA (1) ZA79709B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854659A1 (de) * 1978-12-18 1980-07-10 Boehringer Sohn Ingelheim Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE3168754D1 (en) * 1980-07-09 1985-03-21 Beecham Group Plc Clonidine derivatives useful in the treatment of diarrhoea
EP0070084A3 (fr) * 1981-04-24 1983-02-16 Beecham Group Plc Dérivés d'imidazoline
US4644007A (en) * 1981-11-20 1987-02-17 Alcon Laboratories, Inc. 3-chloro-4-(4,5-dihydro-1H-imidazo-2-yl)-amino-5-alkylbenzoic acids, esters, salts, compositions and methods
CA1201066A (fr) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. Solutions de n-¬3,5-dichloro-4-(2- imidazolidinylidene-amino)-phenyl|-acetamide pour diminuer la pression intra-oculaire
US4461904A (en) * 1981-11-20 1984-07-24 Alcon Laboratories, Inc. 2-(Trisubstituted phenylimino)-imidazolines
US4515800A (en) * 1981-11-20 1985-05-07 Icilio Cavero Method of lowering intraocular pressure using phenylimino-imidazoles
US4517199A (en) * 1981-11-20 1985-05-14 Alcon Laboratories, Inc. Method for lowering intraocular pressure using phenylimino-imidazoles
FR2521140A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives d'imidazolidine, leur preparation et leur application en therapeutique
GB2137191A (en) * 1983-02-28 1984-10-03 Sumitomo Chemical Co Fungicidal N-phenylimidates
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
JP2003166617A (ja) 2001-11-28 2003-06-13 Honda Motor Co Ltd トルクコンバータ付き内燃機関
JP2007308392A (ja) * 2006-05-16 2007-11-29 Bayer Cropscience Ag 殺虫性ベンズアミジン類

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899426A (en) * 1959-08-11 Synthesis of l
US2938038A (en) * 1960-05-24 X-dihydroxyphenylamino
FR1211341A (fr) * 1955-12-19 1960-03-15 A Wander Dr Procédé pour la préparation de 2-amino-imidazolines
US3595961A (en) * 1965-10-01 1971-07-27 Boehringer Sohn Ingelheim Hypotensive compositions containing 2-(2' - halo-anilino) - 1,3 -diazacyclopentenes-(2) and methods of using the same
DE1670274A1 (de) * 1966-10-31 1970-07-16 Boehringer Sohn Ingelheim Neues Verfahren zur Herstellung von 2-Arylamino-1,3-diazacycloalkenen-(2)
AT285599B (de) * 1968-06-21 1970-11-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen trisubstituierten 2-Arylaminoimidazolinen und ihren Salzen
DE2446758C3 (de) * 1974-10-01 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 2-(2-Fluor-6-trifluormethylphenylimino)-imidazolidin, dessen Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung der Hypertonie
DE2523103C3 (de) * 1975-05-24 1979-11-29 C.H. Boehringer Sohn, 6507 Ingelheim Substituierte 2-[N-Progargyl-N-(2-chlorphenyl)amino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung
DE2630060C2 (de) * 1976-07-03 1984-04-19 C.H. Boehringer Sohn, 6507 Ingelheim 2-(2-Brom-6-fluor-phenylimino)-imidazolidin, dessen Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
US4250186A (en) 1981-02-10
IE790311L (en) 1979-08-17
DE2806775A1 (de) 1979-08-30
GB2014575A (en) 1979-08-30
RO81504B (ro) 1983-04-30
NZ189684A (en) 1981-01-23
ZA79709B (en) 1980-10-29
ATA101579A (de) 1982-07-15
SU812175A3 (ru) 1981-03-07
PL116527B1 (en) 1981-06-30
CS207773B2 (en) 1981-08-31
AU519356B2 (en) 1981-11-26
NL7901241A (nl) 1979-08-21
FI69301C (fi) 1986-01-10
YU36779A (en) 1983-04-30
ES477784A1 (es) 1980-04-01
GR69232B (fr) 1982-05-10
CS207774B2 (en) 1981-08-31
FR2417502A1 (fr) 1979-09-14
FI790510A (fi) 1979-08-18
AU4432579A (en) 1979-08-23
JPS54122273A (en) 1979-09-21
PL213475A1 (fr) 1980-03-10
DD142048A5 (de) 1980-06-04
SE7901405L (sv) 1979-08-18
RO81504A (fr) 1983-04-29
HU180430B (en) 1983-03-28
LU80924A1 (de) 1980-04-21
IT7948010A0 (it) 1979-02-15
PT69239A (de) 1979-03-01
IT1113469B (it) 1986-01-20
US4293564A (en) 1981-10-06
IL56678A (en) 1982-01-31
BE874252A (fr) 1979-08-16
CH640230A5 (de) 1983-12-30
GB2014575B (en) 1982-11-10
PL115759B1 (en) 1981-04-30
NO790523L (no) 1979-08-20
FI69301B (fi) 1985-09-30
IL56678A0 (en) 1979-05-31
ES485043A1 (es) 1980-05-16
GR67626B (fr) 1981-09-01
DK69479A (da) 1979-08-18
IE48073B1 (en) 1984-09-19
FR2417502B1 (fr) 1981-06-26
NO151239B (no) 1984-11-26
PH16188A (en) 1983-07-28
CA1115717A (fr) 1982-01-05
RO76799A (fr) 1981-05-30
SU828964A3 (ru) 1981-05-07
AT370093B (de) 1983-02-25

Similar Documents

Publication Publication Date Title
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO151320C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO151964C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(4-pipieridyl)-propaner
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO813821L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO801989L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner